SCHEMBL8993105

SCHEMBL8993105

Cc1cccc(Cc2ccc(-c3cnn4c(O)c(C(=O)O)cnc34)cc2C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRS3 P32247 2/20 0.45
SMN1; SMN2 Q16637 6/20 0.42
ALDH1A1 P00352 3/20 0.42
RAB9A P51151 6/20 0.41
NPC1 O15118 5/20 0.41
KDR P35968 4/20 0.41
MAPT P10636 3/20 0.40
NFKB1 P19838 2/20 0.40
NFKB2 Q00653 2/20 0.40
RELA Q04206 2/20 0.40
KDM4E B2RXH2 2/20 0.40
HCAR2 Q8TDS4 2/20 0.40
GPR119 Q8TDV5 1/20 0.40
TP53 P04637 2/20 0.40
HPGD P15428 1/20 0.39
STAT1 P42224 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KDM5B Q9UGL1 1/20 0.38
THRB P10828 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8993100 0.89 NPC1 (0.53) SMN1; SMN2ALDH1A1RAB9ANPC1KDR
SCHEMBL8993019 0.89 BRS3 (0.47) BRS3SMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL8993229 0.88 BRS3 (0.52) BRS3SMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL8992904 0.81 GPR119 (0.39) SMN1; SMN2ALDH1A1RAB9ANPC1KDR
SCHEMBL8993244 0.80 BRS3 (0.47) BRS3SMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL8992991 0.77 NPC1 (0.57) BRS3SMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL8992832 0.77 RAB9A (0.52) BRS3SMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL8992780 0.76 BRS3 (0.54) BRS3SMN1; SMN2ALDH1A1RAB9ANPC1
SCHEMBL9172965 0.75 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1RAB9ANPC1KDR
SCHEMBL8993124 0.74 GPR119 (0.37) SMN1; SMN2ALDH1A1RAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5516777-A PROSTATE CANCER THERAPY OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1996-05-14 US disclosed
US-5409928-A Prostate diseases, alopecia OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-04-25 US disclosed
EP-0594149-A2 Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-04-27 EP disclosed